The bile acid receptor TGR5 and cholestasis
-
Published:2022-12-30
Issue:
Volume:
Page:154-169
-
ISSN:
-
Container-title:Exploration of Digestive Diseases
-
language:en
-
Short-container-title:Explor Dig Dis
Author:
Merlen Grégory1ORCID, Bidault-Jourdainne Valeska1ORCID, Doignon Isabelle1, Garcin Isabelle1, Tordjmann Thierry1ORCID
Affiliation:
1. INSERM U.1193, Faculté des Sciences d’Orsay, Université Paris Saclay, 91400 Orsay, France
Abstract
During liver injury and cholestasis, the mechanisms allowing the organ to protect itself with the aim of maintaining biliary homeostasis are not completely understood. Central to their biological roles, bile acids (BAs) and their receptors constitute a signaling network with multiple molecular and cellular impacts on both liver repair and protection from BA overload. BA signal through nuclear [mainly farnesoid X receptor (FXR)] and membrane [mainly G protein-coupled BA receptor 1 (GPBAR-1), aka Takeda G protein-coupled receptor 5 (TGR5)] receptors, in which activation elicits a wide array of biological responses. So far, most of the studies have been focused on FXR signaling as hepato-protective, TGR5 being less explored to this regard. While the liver faces massive and potentially harmful BA overload during cholestasis, it is crucial to understand that BAs induce also protective responses contributing not only to reduce the inflammatory burden, but also to spare liver cells and their repair capacities. Based on the available literature, the TGR5 BA receptor protects the liver in the cholestatic context and counteracts BA overload with the aim of restoring biliary homeostasis mainly through the control of inflammatory processes, biliary epithelial barrier permeability, and BA pool composition. Mouse experimental models of cholestasis reveal that the lack of TGR5 was associated with exacerbated inflammation and necrosis, leaky biliary epithelium, and excessive BA pool hydrophobicity, resulting in biliary cell and parenchymal insult, and compromising optimal restoration of biliary homeostasis and liver repair. There are thus widely opened translational perspectives with the aim of targeting TGR5-related signaling or biological responses to trigger protection of the cholestatic liver.
Funder
Institut National de la Santé et de la Recherche Médicale Agence Nationale de la Recherche
Publisher
Open Exploration Publishing
Subject
Marketing,Pharmacy,Health Policy,Pharmaceutical Science,Pharmacology,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Drug Discovery,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Pharmacology,Pharmacology,Toxicology,Pharmacology
Reference134 articles.
1. Dawson PA, Karpen SJ. Intestinal transport and metabolism of bile acids. J Lipid Res. 2015;56:1085–99. 2. Hoekstra LT, van Lienden KP, Schaap FG, Chamuleau RAFM, Bennink RJ, van Gulik TM. Can plasma bile salt, triglycerides, and apoA-V levels predict liver regeneration? World J Surg. 2012;36:2901–8. 3. Debray D, Rainteau D, Barbu V, Rouahi M, El Mourabit H, Lerondel S, et al. Defects in gallbladder emptying and bile acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies. Gastroenterology. 2012;142:1581–91.e6. 4. Bidault-Jourdainne V, Merlen G, Glénisson M, Doignon I, Garcin I, Péan N, et al. TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload. JHEP Rep. 2021;3:100214. 5. Merlen G, Kahale N, Ursic-Bedoya J, Bidault-Jourdainne V, Simerabet H, Doignon I, et al. TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function. Gut. 2020;69:146–57.
|
|